Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2015; 45(1): 6-12


The Effects of Topical Dimethyle Sulfoxide on Second-Degree Burn Wound Healing in Dogs

Ayman Atiba and Alaa Ghazy.




Abstract

Burn injury is a major cause of death and disability worldwide. Healing of burn wounds still remains a challenge to modern medicine. The aim of this study was to investigate the effects of Dimethyl sulfoxide (DMSO) on a second-degree burn wounds and compare it with that of silver sulfadiazine (SSD) 1% cream in dogs. A standard deep second-degree burn wound was produced, five dogs, each dog have three groups, DMSO, SSD and control (untreated). The efficacy of treatment was assessed based on the healing percentage of the wound, time to complete wound healing and the degree of inflammation. Wound contraction was higher in the DMSO group than both SSD and the control group. It was significantly higher in the DMSO group than the control group on days 21 and 24 (P < 0.05). The mean times for wound complete closure were 24.4 ± 2.23 and 25.7 ± 2.31 days for DMSO and SSD, respectively, being shorter for DMSO but not significantly (P> 0.05). Clinically, inflammatory reaction was less in DMSO group than the control group. Topical application of DMSO has significant positive effects on the healing of burn wounds in a dog model.

Key words: DMSO, Dog, Burn, Wound-Healing






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.